About this issue and about the congress …

Abstract

Guidelines are written to be followed and to aid the effective, structured and uniform treatment of patients. Staging systems also aim to stratify and group patients and to instruct therapeutic approaches. We should welcome and adopt these new developments, but not without the necessary scrutiny and criticism. In this journal issue, we publish the newly revised FIGO staging for endometrial cancer, and one of the international members of our editorial board reflects and comments on the changes. Endometrial cancer is often detected and managed by generalist gynaecologists. It is mandatory that the correct staging be adopted by everyone who treats these patients. The commentary includes an interesting discussion on the debate about lymph node assessment in endometrial cancer, and probably accurately reflects the position of the academic units in our country.